Northsight Capital plans to acquire Stargreen Holdings to expand its business and presence in the cannabis industry.
Based on the purchase consideration, Northsight expects the acquisition to cost between $5m and $20m.
The company will issue 210 million of its common stock shares to raise funds for the acquisition.
GL Capital Management and ABG Management plan to acquire SciClone Pharma for a purchase consideration of $570m.
Related
The companies plan to fund the acquisition through debt and equity financing.
Morgan Stanley is acting as transaction adviser, and Skadden Arps, Slate Meagher &Flom and Fangda Law Firm are acting as legal advisers for the acquisition.
Content from our partners
Tonghua Golden Horse Pharmaceutical Industry plans to acquire medicinal materials firm Lhasa.
The company expects the acquisition to cost up to $1.6m.
Related Companies
